| [1] | Nuccil M, Marr KA. Emerging fungal diseases[J]. Clin Infect Dis, 2005, 41: 521. |
| [2] | ODDS FC. Resistance of yeasts to azole-derivative antifungals[J]. J Antimicrob Chemother,1993, 31(4): 46. |
| [3] | Vanden Bossche H, Koymans L, Cytochromes P450 in fungi[J]. Mycoses, 1998,41: (Suppl. l): 32. |
| [4] | Zhao QJ, Song Y, Hu HG, et al. Design, synthesis and antifungal activity of novel triazole derivatives[J]. Chinese Chemical Letters, 2007, 18: 670. |
| [5] | Zhao QJ, Hu HG, Li Yw, et al. Design, Synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14a-demethylase(CYP51)[J]. Chemistry ＆Biodiversity, 2007, 4: 1472. |
| [6] | Chai XY, Zhang J, Yu SC, et al. Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-y1)-2-(2,4-difluoropheny1)-3-substituted benzylamino-2-propanols[J]. Bioorg Med Chem Lett, 2009, 19(6): 1811. |
| [7] | 章杰兵, 但志刚, 柴晓云, 等. 1-(1H-1,2,4-三唑-1-基)-(2,4-二氟苯基)-3-[N-环丙基-N-(4-取代苄基)]-2-丙醇的合成及抗真菌活性[J]. 药学实践杂志, 2009, 27(2): 107. |
| [8] | 赵庆杰, 宋 琰, 胡宏岗, 等. 1-(1H-1,2,4-三唑-1-基)-(2,4-二氟苯基) -3-取代-2-丙醇类化合物的合成及其抗真菌活性[J]. 中国药物化学杂志, 2006, 16(3): 150. |
| [9] | National committee for clinical laboratory standards. Reference method for broth dilution antifungal susceptibility testing of yeasts,approved standard document M27-A2[S], PA: Wayne: 2002. |